Efficacy of elexacaftor/tezacaftor/ivacaftor therapy assessed by lung ultrasound
U. Krivec (Ljubljana, Slovenia), M. Praprotnik (Ljubljana, Slovenia), M. Aldeco (Ljubljana, Slovenia), D. Lepej (Ljubljana, Slovenia), A. Zver (Ljubljana, Slovenia), J. Rodman Berlot (Ljubljana, Slovenia), S. Šetina Šmid (Ljubljana, Slovenia), Š. Dolenc (Ljubljana, Slovenia), J. Lozar Krivec (Ljubljana, Slovenia)
Source: International Congress 2022 – Monitoring the effect of therapy with CFTR modulators
Session: Monitoring the effect of therapy with CFTR modulators
Session type: Oral Presentation
Number: 1620
   
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
U. Krivec (Ljubljana, Slovenia), M. Praprotnik (Ljubljana, Slovenia), M. Aldeco (Ljubljana, Slovenia), D. Lepej (Ljubljana, Slovenia), A. Zver (Ljubljana, Slovenia), J. Rodman Berlot (Ljubljana, Slovenia), S. Šetina Šmid (Ljubljana, Slovenia), Š. Dolenc (Ljubljana, Slovenia), J. Lozar Krivec (Ljubljana, Slovenia). Efficacy of elexacaftor/tezacaftor/ivacaftor therapy assessed by lung ultrasound. 1620
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|